These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 19332771)

  • 1. Giant cell glioblastoma: a glioblastoma subtype with distinct epidemiology and superior prognosis.
    Kozak KR; Moody JS
    Neuro Oncol; 2009 Dec; 11(6):833-41. PubMed ID: 19332771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult gliosarcoma: epidemiology, natural history, and factors associated with outcome.
    Kozak KR; Mahadevan A; Moody JS
    Neuro Oncol; 2009 Apr; 11(2):183-91. PubMed ID: 18780813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features associated with the efficacy of chemotherapy in patients with glioblastoma (GBM): a surveillance, epidemiology, and end results (SEER) analysis.
    Wen J; Chen W; Zhu Y; Zhang P
    BMC Cancer; 2021 Jan; 21(1):81. PubMed ID: 33468109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of gender on the survival of patients with glioblastoma.
    Tian M; Ma W; Chen Y; Yu Y; Zhu D; Shi J; Zhang Y
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30305382
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of pretreatment clinical factors on overall survival in glioblastoma multiforme: a Surveillance Epidemiology and End Results (SEER) population analysis.
    Thumma SR; Fairbanks RK; Lamoreaux WT; Mackay AR; Demakas JJ; Cooke BS; Elaimy AL; Hanson PW; Lee CM
    World J Surg Oncol; 2012 May; 10():75. PubMed ID: 22553975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of care and outcomes of patients with pleomorphic xanthoastrocytoma: a SEER analysis.
    Perkins SM; Mitra N; Fei W; Shinohara ET
    J Neurooncol; 2012 Oct; 110(1):99-104. PubMed ID: 22843450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient and treatment factors associated with survival among pediatric glioblastoma patients: A Surveillance, Epidemiology, and End Results study.
    Lam S; Lin Y; Zinn P; Su J; Pan IW
    J Clin Neurosci; 2018 Jan; 47():285-293. PubMed ID: 29102237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient and treatment factors associated with survival among adult glioblastoma patients: A USA population-based study from 2000-2010.
    Pan IW; Ferguson SD; Lam S
    J Clin Neurosci; 2015 Oct; 22(10):1575-81. PubMed ID: 26122381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Factors and Treatment Patterns in the Management of Giant Cell Glioblastoma.
    Jin MC; Wu A; Xiang M; Azad TD; Soltys SG; Li G; Pollom EL
    World Neurosurg; 2019 Aug; 128():e217-e224. PubMed ID: 31009783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prior malignancies in patients harboring glioblastoma: an institutional case-study of 2164 patients.
    Zacharia BE; DiStefano N; Mader MM; Chohan MO; Ogilvie S; Brennan C; Gutin P; Tabar V
    J Neurooncol; 2017 Sep; 134(2):245-251. PubMed ID: 28551847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes and Patterns of Care in Elderly Patients with Glioblastoma Multiforme.
    Nunna RS; Khalid SI; Patel S; Sethi A; Behbahani M; Mehta AI; Adogwa O; Byrne RW
    World Neurosurg; 2021 May; 149():e1026-e1037. PubMed ID: 33482415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients.
    Zhang G; Huang S; Zhang J; Wu Z; Lin S; Wang Y
    J Neurooncol; 2016 Apr; 127(2):355-62. PubMed ID: 26725096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparities in health care determine prognosis in newly diagnosed glioblastoma.
    Chandra A; Rick JW; Dalle Ore C; Lau D; Nguyen AT; Carrera D; Bonte A; Molinaro AM; Theodosopoulos PV; McDermott MW; Berger MS; Aghi MK
    Neurosurg Focus; 2018 Jun; 44(6):E16. PubMed ID: 29852776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment and survival of patients harboring histological variants of glioblastoma.
    Ortega A; Nuño M; Walia S; Mukherjee D; Black KL; Patil CG
    J Clin Neurosci; 2014 Oct; 21(10):1709-13. PubMed ID: 24980627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival benefit of glioblastoma patients after FDA approval of temozolomide concomitant with radiation and bevacizumab: A population-based study.
    Zhu P; Du XL; Lu G; Zhu JJ
    Oncotarget; 2017 Jul; 8(27):44015-44031. PubMed ID: 28467795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival Analysis of Glioblastoma Multiforme.
    Witthayanuwat S; Pesee M; Supaadirek C; Supakalin N; Thamronganantasakul K; Krusun S
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2613-2617. PubMed ID: 30256068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
    Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
    J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival time trends for glioblastoma using the SEER 17 population-based registries.
    Koshy M; Villano JL; Dolecek TA; Howard A; Mahmood U; Chmura SJ; Weichselbaum RR; McCarthy BJ
    J Neurooncol; 2012 Mar; 107(1):207-12. PubMed ID: 21984115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors and clinical outcomes in adult primary gliosarcoma patients: a Surveillance, Epidemiology, and End Results (SEER) analysis from 2004 to 2015.
    Huang Q; Li F; Chen Y; Hong F; Wang H; Chen J
    Br J Neurosurg; 2020 Apr; 34(2):161-167. PubMed ID: 31829033
    [No Abstract]   [Full Text] [Related]  

  • 20. Pediatric giant cell glioblastoma: New insights into a rare tumor entity.
    Karremann M; Butenhoff S; Rausche U; Pietsch T; Wolff JE; Kramm CM
    Neuro Oncol; 2009 Jun; 11(3):323-9. PubMed ID: 19050301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.